Calcitriol and Subcutaneous nodule - a phase IV clinical study of FDA data

Summary:

Subcutaneous nodule is reported as a side effect among people who take Calcitriol (calcitriol), especially for people who are male, 10-19 old, also take Magnevist, and have Convulsion.

The phase IV clinical study analyzes which people have Subcutaneous nodule when taking Calcitriol. It is created by eHealthMe based on reports of 23,957 people who have side effects when taking Calcitriol from the FDA, and is updated regularly.

What is Calcitriol?

Calcitriol has active ingredients of calcitriol. It is often used in hypoparathyroidism. eHealthMe is studying from 24,162 Calcitriol users. Check the latest studies of Calcitriol.

What is Subcutaneous nodule?

Subcutaneous nodule is found to be associated with 183 drugs and 263 conditions by eHealthMe. Check the latest studies of Subcutaneous nodule.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

23,957 people reported to have side effects when taking Calcitriol.
Among them, 13 people (0.05%) have Subcutaneous nodule.

Could Calcitriol cause Subcutaneous nodule?

Among these 13 people:

What is the gender of people who have Subcutaneous nodule when taking Calcitriol? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Subcutaneous nodule when taking Calcitriol? *

What are other drugs people take besides Calcitriol? *

What are other side effects people have besides Subcutaneous nodule? *

Mobility Decreased (ability to move is reduced): 10 people, 76.92%
Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 9 people, 69.23%
Skin Induration (an abnormally hard spot or area on the skin): 9 people, 69.23%
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue): 8 people, 61.54%
Pain: 7 people, 53.85%
Skin Tightness: 7 people, 53.85%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 6 people, 46.15%
Metaplasia (change in the type of adult cells in a tissue to a form abnormal for that tissue): 6 people, 46.15%
Pain In Extremity: 6 people, 46.15%
Xerosis (abnormal dryness of the skin or mucus membranes): 6 people, 46.15%

What are the existing conditions these people have? *

Renal Osteodystrophy (a bone disease occurs when the kidneys fail to maintain the proper levels of calcium and phosphorus in the blood): 3 people, 23.08%
Nuclear Magnetic Resonance Imaging Brain: 3 people, 23.08%
Joint Pain: 3 people, 23.08%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 3 people, 23.08%
Headache (pain in head): 3 people, 23.08%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 23.08%
Catheter Related Complication: 2 people, 15.38%
Shunt Malfunction: 1 person, 7.69%
Medical Device Complication: 1 person, 7.69%
Juvenile Arthritis (arthritis-related condition that develops in children or teenagers): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Calcitriol and have Subcutaneous nodule?

- Check whether Subcutaneous nodule is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Calcitriol:

Calcitriol (24,162 reports)

Browse all side effects of Calcitriol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Subcutaneous nodule:

Subcutaneous nodule (183 drugs)

Browse all the conditions that are associated with Subcutaneous nodule:

Subcutaneous nodule (263 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on calcitriol (the active ingredients of Calcitriol) and Calcitriol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.